Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP414411.RAqismKF4omgiWWmL0oLfNLGfYtEa0aB1XfOUoovkj1gk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP414411.RAqismKF4omgiWWmL0oLfNLGfYtEa0aB1XfOUoovkj1gk130_assertion type Assertion NP414411.RAqismKF4omgiWWmL0oLfNLGfYtEa0aB1XfOUoovkj1gk130_head.
- NP414411.RAqismKF4omgiWWmL0oLfNLGfYtEa0aB1XfOUoovkj1gk130_assertion description "[A major hurdle for hematopoietic stem cell (HSC) gene therapy for inherited bone marrow disorders, including Fanconi anemia (FA), is adequate engraftment of gene-modified cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP414411.RAqismKF4omgiWWmL0oLfNLGfYtEa0aB1XfOUoovkj1gk130_provenance.
- NP414411.RAqismKF4omgiWWmL0oLfNLGfYtEa0aB1XfOUoovkj1gk130_assertion evidence source_evidence_literature NP414411.RAqismKF4omgiWWmL0oLfNLGfYtEa0aB1XfOUoovkj1gk130_provenance.
- NP414411.RAqismKF4omgiWWmL0oLfNLGfYtEa0aB1XfOUoovkj1gk130_assertion SIO_000772 22660274 NP414411.RAqismKF4omgiWWmL0oLfNLGfYtEa0aB1XfOUoovkj1gk130_provenance.
- NP414411.RAqismKF4omgiWWmL0oLfNLGfYtEa0aB1XfOUoovkj1gk130_assertion wasDerivedFrom befree-20150227 NP414411.RAqismKF4omgiWWmL0oLfNLGfYtEa0aB1XfOUoovkj1gk130_provenance.
- NP414411.RAqismKF4omgiWWmL0oLfNLGfYtEa0aB1XfOUoovkj1gk130_assertion wasGeneratedBy ECO_0000203 NP414411.RAqismKF4omgiWWmL0oLfNLGfYtEa0aB1XfOUoovkj1gk130_provenance.